From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue
Overview
Authors
Affiliations
Nicotinic acetylcholine receptors containing α9 subunits (α9*-nAChRs) are potential druggable targets arousing great interest for pain treatment alternative to opioids. Nonpeptidic small molecules selectively acting as α9*-nAChRs antagonists still remain an unattained goal. Here, through modifications of the cationic head and the ethylene linker, we have converted the 2-triethylammonium ethyl ether of 4-stilbenol (MG624), a well-known α7- and α9*-nAChRs antagonist, into some selective antagonists of human α9*-nAChR. Among these, the compound with cyclohexyldimethylammonium head () stands out for having no α7-nAChR agonist or antagonist effect along with very low affinity at both α7- and α3β4-nAChRs. At supra-micromolar concentrations, and the other selective α9* antagonists behaved as partial agonists at α9*-nAChRs with a very brief response, followed by rebound current once the application is stopped and the channel is disengaged. The small or null postapplication activity of ACh seems to be related to the slow recovery of the rebound current.
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
Dallanoce C, Richter K, Stokes C, Papotto C, Andleeb H, Thakur G ACS Chem Neurosci. 2024; 15(4):827-843.
PMID: 38335726 PMC: 11274740. DOI: 10.1021/acschemneuro.3c00720.
George A, John S, Lucero L, Eaton J, Jaiswal E, Christensen S FASEB J. 2024; 38(1):e23374.
PMID: 38161283 PMC: 10782225. DOI: 10.1096/fj.202302079.
Richter K, Herz S, Stokes C, Damaj M, Grau V, Papke R Neuropharmacology. 2023; 240:109717.
PMID: 37758018 PMC: 11295495. DOI: 10.1016/j.neuropharm.2023.109717.
Shelukhina I, Siniavin A, Kasheverov I, Ojomoko L, Tsetlin V, Utkin Y Int J Mol Sci. 2023; 24(7).
PMID: 37047495 PMC: 10095066. DOI: 10.3390/ijms24076524.
Bavo F, Pallavicini M, Pucci S, Appiani R, Giraudo A, Oh H J Med Chem. 2022; 66(1):306-332.
PMID: 36526469 PMC: 9841521. DOI: 10.1021/acs.jmedchem.2c01256.